↑ 薬物リストへ　← 戻る

Diagnostic test: disease activity    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
46悪性関節リウマチ1

46. 悪性関節リウマチ　［臨床試験数：4,183，薬物数：2,538（DrugBank：401），標的遺伝子数：183，標的パスウェイ数：219］
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4,183 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04194827
(ClinicalTrials.gov)		March 1, 20203/12/2019Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug MonitoringAdalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring (ADDORA): Multi-centre Open Label Randomised Controlled TrailRheumatoid ArthritisDiagnostic Test: Adalimumab serum trough concentration;Diagnostic Test: Disease activity;Drug: AdalimumabReade Rheumatology Research InstituteZonMw: The Netherlands Organisation for Health Research and Development;Sint MaartenskliniekRecruiting18 YearsN/AAll267Phase 4Netherlands